ObjectiveWe investigated the association between the glucocorticoid receptor (GR) gene, also known as the nuclear receptor subfamily 3, group C, member 1 (NR3C1), rs41423247 polymorphism and functional seizures (psychogenic nonepileptic seizures/attacks) in a case‐control study. We hypothesized that the tested polymorphism has significant associations with functional seizures (psychogenic nonepileptic seizures/attacks) independent from comorbid depression.MethodsSeventy patients with functional seizures (psychogenic nonepileptic seizures/attacks), 70 with major depressive disorder (MDD), and 70 healthy controls (HC) were studied. Their DNAs were analyzed for NR3C1 rs41423247 polymorphism.ResultsGenotype and allele frequencies of rs41423247 were different between the three groups. G allele carriers were more frequent in patients with functional seizures (psychogenic nonepileptic seizures/attacks) and those with MDD compared to healthy controls (P=0.0001). However no significant difference was observed with respect to allele distributions between functional seizures (psychogenic nonepileptic seizures/attacks) and MDD groups (P=0.391). CC genotype was less often associated with functional seizures (psychogenic nonepileptic seizures/attacks) vs. HC: Codominant model; P=0.001, OR= 0.11, 95% CI=0.05‐0.24, and ‐2loglilkelihood=231.7. In comparison between functional seizures (psychogenic nonepileptic seizures/attacks) group and other (MDD+HC) groups, we observed a significant association between CG genotype and functional seizures (psychogenic nonepileptic seizures/attacks) (Codominant model; P=0.001, OR=5.63, 95% CI=2.60‐12.40 and ‐2loglikelihood=245.99).SignificancePatients with functional seizures (psychogenic nonepileptic seizures/attacks) and those with MDD were significantly more often G allele carriers in rs41423247 compared with healthy controls. We observed a significant association between CG genotype and functional seizures (psychogenic nonepileptic seizures/attacks). However, we could not exclude the possibility of confounding effects of depression. Future genetic studies of patients with functional seizures (psychogenic nonepileptic seizures/attacks) should include a comparison group with depression in addition to a comparison group of healthy controls.